Amaziah J
For patients with an A1C of 6.5% to 7.5%, metformin is the preferred initial agent, with GLP-1 receptor agonists, dipeptidyl-peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), or an alpha-glucosidase inhibitor listed as viable alternatives
What you probably haven't figured out yet is whether the injectable or oral form is the better fit for your body and your daily life
it was a fundamental transformation to unify how people experience the brand across their physical and digital lives, said Kate Wadia, founder and chief creative officer, Mrs&Mr
One in-vitro study found that this ingredient tells your skin cells to produce more of the proteins (filaggrin, loricrin, and involucrin) for building a strong and healthy barrier
from the National Cancer Institute (USA)